prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumB, page 1 / 2. conv No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: 1. lesion excision - from the left breast outer upper quadrant. Unit in charge: Central C. Expected time of examination: 5 working days. Clinical diagnosis: and left axillary nodes in one block. Results of immunohistochemicarexaminanon: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell. nuclei. HER2 protein stained with HercepTest™M by DAKO. Score = 2+, FISH verification recommended. Macroscopic description: Partial resection of breast - outer upper quadrant. Breast segment sized 8.4 x 7.4 x 2.6 cm with a 2.8 x 6.8 cm skin flap and axillary tissue sized 8 x 9 x 2, no RTG. Tumour cross section sized 3.0 x 1.8 x 2.9 cm. Margin: to the base 0.1 cm, to the front skin surface 0.2 cm, to the sternum 3.5 cm, to the axilla 2.2 cm, to the shoulder 1.3 cm,. lower 0.8 cm. Microscopic description: Carcinoma ductale invasivum NHG3 (3 + 2 + 3/19 mitoses/10 HPF - visual area of 0.55 mm). Largest dimension of the lesion 3.0 cm. Minimum margin at the base side < 0.05 cm. The other margins as in macroscopic description. Lymph nodes: Metastases carcinomatosae in lymphonodis (No II / XIII). Infiltratio carcinomatosa capsulae lymphonodorum et telae adiposae perinodalis. Histopathological diagnosis: Carcinoma ductale invasivum NHG3, pT2, pN1a. Invasive ductal carcinoma of the left breast. Compliance validated t. Examination: Intraoperative examination. page 2 / 2. Fyamination No.: Results of immunohistochemical. examination: RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by Path Vysion HER2 DNA Probe Kit. HER-2 GENE AMPLIFICATION NOT FOUND.

expanded version (tokens=927) : 
 Histological classification: The patient has a LumB subtype of invasive ductal carcinoma in the left breast. 

Subtype: LumB

Description of necrosis: There is no mention of necrosis in the report.

Tumor infiltrating lymphocytes: There is no mention of tumor infiltrating lymphocytes in the report.

Histological grade: The histological grade of the cancer is NHG3 (3 + 2 + 3/19 mitoses/10 HPF - visual area of 0.55 mm).

Nuclear grade: The nuclear grade of the cancer is not explicitly mentioned, but the histological grade of NHG3 indicates a high nuclear grade.

Lymphovascular invasion: There is no mention of lymphovascular invasion in the report.

Calcification: There is no mention of calcification in the report.

Receptor status: The cancer cells have estrogen and progesterone receptors found in over 75% of the neoplastic cell nuclei. 

IHC and ancillary testing results: HER2 protein was stained with HercepTest™M by DAKO and scored as 2+. However, the FISH verification recommended for HER2 gene amplification was negative. Metastatic carcinoma was found in the lymph nodes (No II / XIII). 

Overall, the patient has a LumB subtype of invasive ductal carcinoma in the left breast with positive estrogen and progesterone receptors, but negative HER2 gene amplification. There is lymph node involvement

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1030) : 
 The patient's breast pathology report indicates a LumB subtype of invasive ductal carcinoma with positive estrogen and progesterone receptors, but negative HER2 gene amplification. The histological and nuclear grades were NHG3 (high grade), with metastases in the lymph nodes.

